Sangamo BioSciences | SGMO - أسهم رأس المال العادية





أسهم رأس المال العادية تغيير تاريخ
Alaunos Therapeutics USD 2.21M 131K 2025-09
Alnylam Pharmaceuticals USD 132.38M 585K 2025-12
Alterity Therapeutics Limited AUD 213.97M 144.39K 2023-06
Amgen USD 539M 1000K 2025-12
Bayer EUR 982.42M 0 2025-12
BioCryst Pharmaceuticals USD 213.06M 2.54M 2025-12
Biogen USD 146.7M 200K 2025-09
BioMarin Pharmaceutical USD 192.3M 201K 2025-12
Cipla INR 807.77M 807.43M 2025-09
Clal Biotechnology ILS 1.61M 0 2022-12
Compugen USD 94.55M 1.02M 2025-12
CSL USD 482.13M 93.87M 2025-12
Gilead Sciences USD 1.24B 1000K 2025-12
GlaxoSmithKline GBP 4.08B 49.43M 2025-12
Grifols EUR 680.58M 846.11K 2025-12
Ionis Pharmaceuticals USD 161.97M 836K 2025-12
J&J USD 2.41B 584K 2025-09
Karyopharm Therapeutics USD 13K 0 2024-09
Merck USD 2.49B 15.79M 2025-09
Novartis USD 1.91B 10.64M 2025-12
Omeros USD 611K 17K 2023-12
Pfizer USD 5.69B 1000K 2025-09
Roche Holding CHF 795.62M 699.54K 2025-12
Sarepta Therapeutics USD 104.96M 196K 2025-12
Tectonic Therapeutic USD 18.74M 25.03K 2025-12
Ultragenyx Pharmaceutical USD 96.44M 88K 2025-09
Vertex Pharmaceuticals USD 254M 0 2025-12